The biotech industry is showing encouraging signs of recovery. Hear Labshares CEO Philip Borden's perspective on the growing optimism across the market and what we're seeing firsthand throughout the biotech community.

Diagonal Therapeutics used Labshares' flexible lab space, advanced equipment, and operational support to grow from 4 to 17 employees, advance its agonist antibody pipeline, and raise $128 million in equity financing.

Labshares Newton, a shared office and laboratory space for emerging biotechnology and life science companies, announced that it has selected three startup companies developing COVID-19 diagnostics to receive free lab space.